天士力2025年度归母净利润11.05亿元 同比增加15.68%

Core Insights - The company Tianjin Tasly Pharmaceutical (600535.SH) reported a total operating revenue of 8.236 billion yuan for the year 2025, representing a year-on-year decrease of 3.08% [1] - The net profit attributable to shareholders of the listed company reached 1.105 billion yuan, showing a year-on-year increase of 15.68% [1] - The decline in operating revenue is primarily attributed to a 14.24% decrease in pharmaceutical commercial revenue, mainly from the chain pharmacy business, due to industry-wide policy impacts such as "outpatient coordination" [1]